Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2023-07-05 00:00:00 ET · period of report 2023-07-03 · accession 0001209191-23-041330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-07-03 | MIRM | Peetz Christopher | Pres, CEO, Dir | S - Sale | $25.65 | -5,498 | 115.3K | -5% | -$141.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-03 | S | D | 5,498 | $25.65 | 115,334 | D | — | — |